Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2000
11/08/2000EP1049782A1 Mutants of il-16, processes for their production, and their use
11/08/2000EP1049775A1 Human btrcp protein
11/08/2000EP1049711A1 Liposomes comprising peptide antigens derived from x protein of hepatitis b virus
11/08/2000EP1049703A1 N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl)acetoxyl]-l-aspartic acid aldehyde as an in vivo inhibitor of interleukin-1beta converting enzyme
11/08/2000EP1049701A1 Tricyclic indolene substituted oxazolidinones
11/08/2000EP1049699A1 Azolo triazines and pyrimidines
11/08/2000EP1049694A1 Benzothiadiazoles and derivatives
11/08/2000EP1049692A1 Novel bicyclene-substituted oxazolidinones
11/08/2000EP1049682A1 Oxazolidinone combinatorial libraries, compositions and methods of preparation
11/08/2000EP1049675A1 Chemokine receptor antagonists and methods of use therefor
11/08/2000EP1049667A1 Novel naphthyl substituted and heterocyclic substituted sulfonamides
11/08/2000EP1049666A1 Novel naphthyl-substituted and anilide-substituted sulfonamides
11/08/2000EP1049490A2 Method for inhibiting cd95-independent apoptosis in aids
11/08/2000EP1049488A1 METHOD OF AND COMPOSITIONS FOR IMMUNIZATION WITH THE $i(PSEUDOMONAS) V ANTIGEN
11/08/2000EP1049484A1 Method of using il-11 to enhance cell mediated immunity for treating various viral and parasitic infections and cancer
11/08/2000EP1049481A2 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same
11/08/2000EP1049480A1 Herbal anti-viral agent
11/08/2000EP1049467A1 Celecoxib compositions
11/08/2000EP1049459A1 Oral liquid compositions
11/08/2000EP1049378A2 An antimicrobial composition
11/08/2000EP1049374A1 Tuberculocidal disinfectant
11/08/2000EP0789564A4 Polynucleotide compositions
11/08/2000EP0652872B1 Optically pure magnesium -salt of pyridinylmethyl sulfinyl-1h-benzimidazole compound
11/08/2000EP0635132B1 Broadly reactive opsonic antibodies that react with common staphylococcal antigens
11/08/2000CN1272841A Novel lactam metalloprotease inhibitors
11/08/2000CN1272793A Method of protecting against chronic infections
11/08/2000CN1272792A Herbal extract composition and method with immune-boosting capability
11/08/2000CN1272362A Selective antibiotic composition
11/08/2000CN1058296C Antibody heteroconjugates for use in regulation lymphocyte activity
11/08/2000CN1058294C Method for preparation of compound named 'Leustroducsins'
11/08/2000CN1058191C 疫苗 Vaccine
11/08/2000CN1058150C Topical aromatic releasing compositions
11/08/2000CN1058149C Perfume for curing tinea manuum and tinea pedis
11/07/2000US6143876 Immunogenic antigenic epitope which is a member of a binding couple; for production of antibodies with increased affinity; diagnosis; treatment; vaccines; viricides against human immunodeficiency virus
11/07/2000US6143795 Stable mitoxantrone solutions
11/07/2000US6143794 Topical formulations for the treatment of nail fungal diseases
11/07/2000US6143793 Use of hydrophilic penetration agents in dermatological compositions for the treatment of onychomycoses, and corresponding compositions
11/07/2000US6143780 Compounds for treatment of aids containing furan or thiophene groups
11/07/2000US6143776 Enzyme inhibitors of thymidylate synthase
11/07/2000US6143771 Benzimidazole derivative drugs
11/07/2000US6143749 Heterocyclic substituted cyclopentane compounds
11/07/2000US6143747 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
11/07/2000US6143742 Treatment for necrotizing infections
11/07/2000US6143739 Antimicrobial agents mainly active against gram positive bacteria
11/07/2000US6143728 Guanylhydrazones useful for treating diseases associated with T cell activation
11/07/2000US6143715 For treating and prevention of hepatitis c viurs infections
11/07/2000US6143521 Human bombesin receptor subtype-3sb
11/07/2000US6143490 In vitro method for deactivation of viral, bacterial, or protozoan pathogen by adding compound consisting of intercalator nucleic acid binding ligand and an attached mustard group, treating the mixture, and recovering blood
11/07/2000US6143318 Antimicrobial composition composed of controlled release glasses
11/07/2000US6143299 Compositions and methods using complexes of heat shock protein gp96 and antigenic molecules for the treatment and prevention of infectious diseases
11/07/2000CA2166981C Oncoprotein protein kinase
11/03/2000CA2270600A1 Method and formulations for the treatment of diseases, particularly those caused by human immunodeficiency virus and leishmania
11/02/2000WO2000065057A1 Inhibition of viral infection using monovalent antigen-binding proteins
11/02/2000WO2000065054A2 Human membrane-associated proteins
11/02/2000WO2000065032A1 Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142
11/02/2000WO2000065028A2 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR
11/02/2000WO2000064939A2 Peptides derived from vasostatin i and the use thereof as anti-fungal agents
11/02/2000WO2000064937A1 Inactivated cytokines for immunisation
11/02/2000WO2000064936A2 PEPTIDE HOMODIMERS AND PEPTIDE HETERODIMERS, DERIVED FROM INTERFERON α2
11/02/2000WO2000064927A1 Cyclic hexapeptides having antibiotic activity
11/02/2000WO2000064915A1 Novel disaccharide antibacterial agents
11/02/2000WO2000064911A1 Ligands for metabotropic glutamate receptors
11/02/2000WO2000064903A2 Methods for preparing antiviral calanolide compounds
11/02/2000WO2000064894A1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
11/02/2000WO2000064891A1 Farnesyl transferase inhibitors having a pyrrole structure and process for preparation thereof
11/02/2000WO2000064878A1 Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors
11/02/2000WO2000064488A2 Somatic transgene immunization and related methods
11/02/2000WO2000064487A2 Delivery of antimicrobial toxins
11/02/2000WO2000064485A2 Specifically targeted catalytic antagonists and uses thereof
11/02/2000WO2000064435A1 Percutaneous absorption preparations containing oxybutynin
11/02/2000WO2000064434A1 Percutaneous preparations containing oxybutynin
11/02/2000WO2000064427A2 Lamivudine containing pharmaceutical formulation
11/02/2000WO2000042987A3 Targeted vesicular constructs for cytoprotection and treatment of h. pylori infections
11/02/2000WO2000041528A3 Improved controlled release compositions and method
11/02/2000WO2000040714A3 Therapeutic phosphodiesterase inhibitors
11/02/2000WO2000040172B1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents
11/02/2000WO2000039299A3 Streptococcus antigens
11/02/2000WO2000039143A3 Antiviral nucleoside analogues
11/02/2000WO2000039083A3 Pyrazole compounds and uses thereof
11/02/2000WO2000038712A3 Method for producing autogenous vaccines for treating chlamydial infections in mammals and humans
11/02/2000WO2000037464A3 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors
11/02/2000WO2000035408A3 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil
11/02/2000WO2000012508B1 Pyrrolbenzodiazepines
11/02/2000EP1047784A2 Neissera meningitidis antigens
11/02/2000EP1047770A1 Histidine kinase
11/02/2000EP1047769A1 Novel therapeutic uses of heterologous superoxide dismutase (hsd), and method for selecting said hsd
11/02/2000EP1047703A1 A combinatorial library of moenomycin analogs and methods of producing same
11/02/2000EP1047692A1 Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof and methods of treating bacterial and microbial infections with these inhibitors
11/02/2000EP1047683A1 Thioether furan nitrone compounds
11/02/2000EP1047656A1 Alkenyldiarylmethane non-nucleoside hiv-1 reverse transcriptase inhibitors
11/02/2000EP1047454A1 Methods of screening compounds useful for prevention of infection or pathogenicity
11/02/2000EP1047448A1 Dna vaccines against tick-borne flaviviruses
11/02/2000EP1047447A1 LIPOOLIGOSACCHARIDE-BASED VACCINE FOR PREVENTION OF $i(MORAXELLA) $i((BRANHAMELLA)) $i(CATARRHALIS) INFECTIONS IN MAMMALS
11/02/2000EP1047446A1 Vaccine composition for herpes simplex virus and methods of using
11/02/2000EP1047431A1 Pharmaceutically active compounds and methods of use thereof
11/02/2000EP1047425A1 Integrin receptor antagonists
11/02/2000EP1047422A1 Use of histamine for elevating blood histamine levels
11/02/2000EP1047395A1 Mixture containing honey, at least one essential oil and/or at least one essential oil derivative
11/02/2000EP1047301A1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv)
11/02/2000EP0683816B1 Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines
1 ... 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 ... 1798